Publicaciones en colaboración con investigadores/as de Hospital General Universitario Reina Sofía (2)

2017

  1. Neoadjuvant therapy with weekly nanoparticle albumin-bound paclitaxel for luminal early breast cancer patients: Results from the nabrax study (GEICAM/2011-02), a multicenter, non-randomized, phase ii trial, with a companion biomarker analysis

    Oncologist, Vol. 22, Núm. 11, pp. 1301-1308

2016

  1. Nab-Paclitaxel in metastatic breast cancer: Defining the best patient profile

    Current Cancer Drug Targets, Vol. 16, Núm. 5, pp. 415-428